Sponsored by:

Nuclear Medicine: Page 212

Bracco to return CardioGen PET tracer to market in Q1
By Wayne Forrest
Contrast agent developer Bracco Diagnostics anticipates that shipments of its CardioGen-82 cardiac PET radiopharmaceutical will resume by the end of the first quarter, after the company voluntarily recalled the product six months ago.
January 4, 2012
2012 01 04 15 15 30 885 Cardio Gen Mild Il Ischemia Thumb
Lantheus CFO retires
By AuntMinnie.com staff writers
Lantheus Medical Imaging's chief financial officer (CFO), Robert Gaffey, has retired effective January 3.
January 3, 2012
PET tracer 4DST beats FDG for imaging cancer proliferation
By Wayne Forrest
A Japanese study highlights the benefits of a new PET radiotracer for imaging the proliferation of cancer cells in non-small cell lung cancer (NSCLC), as compared with PET's workhorse radiopharmaceutical, FDG. The new tracer may also help noninvasively reveal the DNA synthesis of NSCLC cells.
December 29, 2011
GE to settle $30M Medicare fraud lawsuit
By AuntMinnie.com staff writers
GE Healthcare will pay $30 million to the U.S. Centers for Medicare and Medicaid Services to settle a lawsuit alleging Medicare overbilling for the cardiac radiopharmaceutical Myoview, as reported on December 29 by Crain's Detroit Business.
December 28, 2011
Johns Hopkins gets $8M cancer research grant
By AuntMinnie.com staff writers
Johns Hopkins University has received a five-year research grant worth more than $8 million from the U.S. National Cancer Institute to study early diagnostic tests and new treatments for breast, prostate, and other common cancers.
December 27, 2011
Philips moves nuke med jobs to Ohio
By AuntMinnie.com staff writers
Philips Healthcare plans to consolidate its nuclear medicine division by relocating approximately 100 jobs from San Jose, CA, to Highland Heights, OH, according to a report from Cleveland.com.
December 19, 2011
AAPM cautions against skipping imaging
By AuntMinnie.com staff writers
The American Association of Physicists in Medicine (AAPM) is cautioning patients not to forego essential medical imaging tests due to speculation about the risks of radiation exposure.
December 19, 2011
Positron receives pharmacy license
By AuntMinnie.com staff writers
Molecular imaging developer Positron has received a nuclear pharmacy license from the Indiana Board of Pharmacy for its manufacturing facility in Crown Point, IN.
December 19, 2011
PET/MRI comparable to PET/CT in oncologic applications
By Wayne Forrest
For the first time, researchers have shown that whole-body PET/MR can detect hypermetabolic lesions in cancer patients with similar sensitivity to PET/CT, setting the foundation for future studies to validate the use of PET/MR for specific clinical indications.
December 15, 2011
2011 12 12 11 49 21 346 Biograph M Mr Whole Body Thumb
Covidien to spin off division that sells moly isotopes
By AuntMinnie.com staff writers
Healthcare technology firm Covidien plans to spin off its pharmaceuticals business into a standalone public company in a deal that includes Covidien's activities in distributing the molybdenum-99 radioisotope, the firm announced on December 15.
December 14, 2011
Nordion nets profit in FY11
By AuntMinnie.com staff writers
Citing growth among its key products, Nordion achieved double-digit growth in its 2011 fiscal year, although fourth-quarter numbers dipped.
December 14, 2011
ASNC joins Choosing Wisely
By AuntMinnie.com staff writers
The American Society of Nuclear Cardiology (ASNC) has joined the ABIM Foundation and nine medical specialty societies in Choosing Wisely, a campaign aimed at developing evidence-based lists to help guide appropriate use of healthcare resources.
December 14, 2011
Previous Page
Page 212 of 440
Next Page